Avi Priel, PhD

Cancer pain, from tumor metastasis or chemotherapy, dramatically hampers a cancer patient’s quality of life, even with painkillers. The main analgesics for cancer pain are opioids. While opioids help in early stages of cancer, the need to increase the dosage or switch to a more potent opioid leads to devastating adverse effects. A treatment alternative, medical cannabis, comprises many plant subtypes with different pain-alleviation properties. Prof. Priel is studying phytocannabionoids to provide a roadmap for developing non-opioid drugs for cancer pain.

View Grant Recipient Profile